Update shared on 18 Nov 2025
Fair value Increased 0.28%Straumann Holding’s analyst price target saw a modest increase, rising from CHF 111.29 to CHF 111.61. Analysts point to improved investor sentiment and gradual operational momentum reflected in recent research updates.
Analyst Commentary
Recent Street research reflects a mix of optimism and caution among analysts following Straumann Holding's latest results. Their updates shed light on key factors influencing the company's outlook and valuation going forward.
Bullish Takeaways
- Bullish analysts point to gradually improving operational momentum in the U.S., a region considered pivotal for Straumann's growth trajectory.
- Some price target upgrades signal a shift in sentiment, with a belief that negative catalysts are now limited following the Q3 results.
- The overall tone among optimistic analysts centers on reduced investor uncertainty, which supports higher valuation multiples.
- Expectations for improved execution and stabilization in near-term results have prompted upgrades to neutral or buy recommendations.
Bearish Takeaways
- Bearish analysts remain cautious due to reduced growth and margin forecasts, particularly as the recovery in the U.S. market appears slower than initially anticipated.
- Multiple price target cuts reflect a more conservative stance on Straumann's earnings outlook and potential headwinds in core markets.
- There is lingering concern over the company's ability to sustain margin expansion in light of evolving market conditions and competition.
- Some analysts maintain a sell or neutral rating, citing limited upside in the current valuation given ongoing operational challenges.
What's in the News
- Straumann Holding AG recently hosted an Analyst/Investor Day, providing deeper insight into its strategy and business updates. (Key Developments)
- Straumann Group and Smartee Denti-Technology have formed a strategic partnership focusing on the joint development of next-generation orthodontics platforms and innovations in clear aligner technology. This partnership includes a minority equity investment by Smartee. (Key Developments)
- Straumann Group announced new strategic partnerships to advance its orthodontics business, with the goal of accelerating innovation and improving efficiency and profitability for its ClearCorrect brand through collaborative efforts with Smartee. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has risen slightly from CHF 111.29 to CHF 111.61.
- Discount Rate increased mildly from 4.48% to 4.57%.
- Revenue Growth forecast edged up from 8.13% to 8.25%.
- Net Profit Margin dipped marginally from 21.36% to 21.28%.
- Future P/E multiple is up modestly from 28.98x to 29.14x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.